Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens

G. H. Ross, L. B. Hovde, K. H. Ibrahim, Y. H. Ibrahim, J. C. Rotschafer

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

In an in vitro pharmacodynamic model, a twice-daily cefdinir dosing regimen was more effective than a once-daily regimen against common bacterial respiratory pathogens in producing 3-log10 killing and preventing the occurrence of regrowth at 24 h. Twice-daily administration is likely the more appropriate cefdinir dosing strategy for the treatment of community-acquired pneumonia.

Original languageEnglish (US)
Pages (from-to)2936-2938
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume45
Issue number10
DOIs
StatePublished - Oct 9 2001

Fingerprint Dive into the research topics of 'Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens'. Together they form a unique fingerprint.

  • Cite this